Promising New TB Drugs Put on a Fast Track - Science Speaks blog
From the blog post:
"This afternoon, Dr. Mel Spigelman, president and CEO of the Global Alliance for TB Drug Development, and other leading TB advocates will join with FDA Commissioner Margaret Hamburg to launch a new initiative designed to accelerate the development and approval of life-saving new treatments for tuberculosis. There are now at least 9 promising new TB drugs in the pipeline."
About Me
- kys
- My name is Kaya Shah, and I grew up in Knoxville, TN, a city nestled in a valley of the Smokey Mountains. I moved to Boston to study physics and planetary science at MIT. After graduating, I researched pediatric HIV and TB diagnostics with the President's Emergency Plan for AIDS Relief at the Harvard School of Public Health. I received my M.D. from Loyola Stritch School of Medicine in Chicago. While at Stritch, I participated in a service trip to Fond-des-blancs, Haiti, six months after the 2010 earthquake. I am currently a resident in the anesthesiology residency program at Loyola University Medical Center. I remain interested in medical mission trips.
No comments:
Post a Comment